海外の治験の状況「1」での検索結果
11979件の検索結果
- 進捗状況
- 試験名
- 対象疾患名
- 地域
- 登録日
Authorised
- Multi-center, open-label trial to evaluate the safety and tolerability of Alpha-1 MP in subjects with Alpha-1-antitrypsin (a1AT) deficiency. STAMP: Safety and Tolerability of Alpha-1 MP - STAMP
- Alpha-1 Antitrypsin (AAT) deficiency MedDRA version: 9 Level: LLT Classification code 10001806
- United Kingdom
- 2006-02-28
Not recruiting
- Phase-I Study Evaluating the Pharmacokinetic Profile of RhuDex®
- Pharmacokinetics
- United Kingdom
- 2007-09-18
Not recruiting
- Phase I Study in Patients With Solid Tumours
- Neoplasms
- France, Netherlands, Norway, United Kingdom
- 2007-07-03
Not recruiting
- Phase I Study of WX-037 Alone and in Combination With WX-554 in Solid Tumours
- Advanced Solid Tumours
- United Kingdom
- 2013-04-23
Not recruiting
- A Phase I Study to Evaluate the Safety and Immunogenicity of PnuBioVax
- Pneumococcal Infection;Pneumococcal Infection
- United Kingdom
- 2015-10-06
Recruiting
- A Phase I Study for Safety and Tolerability of AL002.
- Healthy;Alzheimer Disease
- Australia, United Kingdom, United States
- 2018-08-15
Recruiting
- Pancreatic Stone Protein (PSP) in Pregnant Women
- Pregnancy;HELLP Syndrome;Preterm Premature Rupture of Fetal Membranes;Preeclampsia
- Switzerland
- 2014-09-17
Recruiting
- Early Diagnosis of the GLUT1 Deficiency Syndrome With a Blood Based Test
- Glut1 Deficiency Syndrome;De Vivo Disease;Seizures;Movement Disorders;Intellectual Disability;Ataxia
- France
- 2018-10-25
Not recruiting
- Safety, Tolerability, Pharmacokinetics, And Pharmacodynamics Study Of PF-04447943, Co-Administered With And Without Hydroxyurea, In Subjects With Stable Sickle Cell Disease
- Phase 1 Sickle Cell;Phase 1 Sickle Cell;Phase 1 Sickle Cell;Phase 1 Sickle Cell
- Belgium, France, Italy, Netherlands, United Kingdom, United States
- 2014-04-07
Not Recruiting
- Ensayo clínico abierto, aleatorizado, para comparar la calidad de vida de los pacientes VIH+ que inician monoterapia con comprimidos de LPV/r vs triple terapia que contengan un IP potenciado - QoL-KAMON
- Pacientes infectadis por VIH-1
- Spain
- 2009-10-26